PALBOREST 75 TABLET 7'S

Content Reviewed By:

Written By:

• PALBOREST 75 TABLET 7'S is a targeted therapy medication primarily used in the treatment of advanced or metastatic breast cancer. Specifically, it is indicated for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. This means that the cancer cells have receptors for hormones like estrogen and progesterone, but do not overexpress the HER2 protein. By targeting the mechanisms that drive cancer cell growth, PALBOREST 75 TABLET 7'S helps to slow down or stop the progression of the disease, improving outcomes for patients with this specific type of breast cancer.
• One of the key benefits of PALBOREST 75 TABLET 7'S is its ability to inhibit cyclin-dependent kinases 4 and 6 (CDK4/6). These enzymes play a crucial role in cell division and proliferation. By blocking CDK4/6, PALBOREST 75 TABLET 7'S disrupts the cell cycle, preventing cancer cells from multiplying uncontrollably. This targeted approach helps to control the growth and spread of the cancer, offering a more precise and effective treatment option.
• When used in combination with hormone therapy, PALBOREST 75 TABLET 7'S has demonstrated significant improvements in progression-free survival (PFS). This means that patients taking PALBOREST 75 TABLET 7'S along with hormone therapy experience a longer period of time without their cancer progressing compared to those receiving hormone therapy alone. This extended period of disease control can have a substantial impact on quality of life and overall survival.
• Clinical trials have shown that PALBOREST 75 TABLET 7'S is generally well-tolerated, with manageable side effects. Common side effects may include neutropenia (low white blood cell count), fatigue, nausea, and hair thinning. However, these side effects are typically monitored and managed by healthcare professionals, ensuring that patients can continue treatment with minimal disruption to their daily lives. The manageable side effect profile, combined with the drug's efficacy, makes it a valuable option for many patients with advanced breast cancer.
• PALBOREST 75 TABLET 7'S offers a targeted approach to treating HR+, HER2- breast cancer by inhibiting CDK4/6, leading to improved progression-free survival when combined with hormone therapy. Its manageable side effect profile makes it a valuable option in managing this condition.

• PALBOREST 75 TABLET 7'S should be taken exactly as prescribed by your doctor. It's crucial to adhere to the dosage and timing instructions provided. Typically, this medication is taken orally, with or without food, usually once daily for 21 consecutive days followed by 7 days off treatment. This cycle is then repeated.
• Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet, as this can affect how the medication is absorbed in your body. Taking it at the same time each day helps maintain a consistent level of the drug in your system, maximizing its effectiveness.
• If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one. Consistent adherence to the prescribed schedule is essential for the best results.
• It's important to continue taking PALBOREST 75 TABLET 7'S for the entire duration prescribed by your doctor, even if you start feeling better. Prematurely stopping the medication can reduce its effectiveness and may lead to a recurrence of your condition. Regularly consult with your doctor to monitor your progress and discuss any concerns or side effects you may be experiencing.